A hospital cannot establish the cost of a surgical robot from the price of the console alone. The useful comparison is a specified clinical programme with a defined instrument set, support agreement and anticipated caseload. The previous version's uncited list prices, market-share figures and generalised clinical-benefit claims have been removed.
Request comparable quotations
| Cost component | Detail to request |
|---|---|
| Acquisition or lease | Exact model, included equipment, term, financing charges and end-of-term obligations |
| Instruments | Unit cost, permitted uses, replacement rules and expected case mix |
| Consumables | Drapes, accessories and any procedure-specific items |
| Service | Coverage hours, preventive maintenance, response terms and exclusions |
| Implementation | Installation, room adaptation, staff training and credentialing support |
| Software | Licences, updates, remote connectivity and ongoing charges |
Ask each vendor to price the same expected procedure mix and annual volume. Keep commercial assumptions separate from clinical eligibility. A system available in one country may have a different authorised indication or availability in another.
Calculate a scenario, not a market average
Suppose an illustrative proposal has a $2 million capital cost spread over seven years, $150,000 annual service expense and $1,200 variable instrument and consumable cost per case. Ignoring financing, tax, residual value and room costs, annual fixed cost is about $435,714.
| Hypothetical annual case volume | Fixed cost per case | Fixed plus assumed variable cost |
|---|---|---|
| 250 | $1,743 | $2,943 |
| 500 | $871 | $2,071 |
| 1,000 | $436 | $1,636 |
These are deliberately illustrative inputs, not vendor quotes, reimbursement rates or expected clinical outcomes. Add staffing, sterilisation, theatre time and other relevant costs before comparing alternatives. Use realistic completed cases rather than maximum equipment capacity.
Verify intended use separately
For an example of a device-specific decision, the FDA's Senhance K233866 record describes a surgeon-controlled system and the indications covered by that decision. The use of such a system does not establish that a procedure is better for every patient. Clinical assessment and training requirements belong with qualified clinicians and the institution's governance process.
Search the exact device and submission in the FDA's 510(k) database where that pathway applies. Match the manufacturer, device version, indication and decision record. Clearance of one device does not cover a whole manufacturer's catalogue or all types of surgery.
Make the contract measurable
Ask for a written installation acceptance process, service escalation plan and arrangements for instrument availability. Model a lower-volume year and service interruption before accepting an economic case. Compare purchase and lease proposals over the same term, including exit costs.
Our medical robot category is a discovery directory. It is not a clinical recommendation or proof of authorisation for a particular use.
Review uncertainty before approval
Give finance, clinical, infection-control, biomedical-engineering and operating-theatre teams the same scenario. Ask each team to identify missing costs and constraints, then record an owner for every unresolved item. Test lower case volume, delayed training, extra instruments, service interruption and an earlier replacement date. The approval paper should show which inputs came from a quotation, which came from hospital records and which remain assumptions.
Before signature, match the quotation's model and software version to the regulatory and clinical review. Define who bears costs if installation, training or acceptance is delayed. Set a date for reviewing actual case volume, recurring spend and service events after deployment so later decisions use the hospital's own record.
